Results
1 -
9 of
9Jean-Baptiste Arlin, Andrea Johnston, Gary J. Miller, Alan R. Kennedy, Sarah L. Price and Alastair J. Florence.
A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV), CrystEngComm, 2010, 12, 64. A. Johnston, A. J. Florence, P. Fernandes, N. Shankland and A. R. Kennedy.
10,11-Dihydrocarbamazepine-formamide solvate (1/1), Acta Cryst. (2007). E63, o3888-o3889Â Â Â Â Charlotte K. Leech, Alastair J. Florence, Kenneth Shankland, Norman Shankland and Andrea Johnston .
10,11-Dihydrocarbamazepine (form III) , Acta Cryst (2007). E63, o675-o677 Â Â William T. A. Harrison, H. S. Yathirajan and H. G. Anilkumar .
An orthorhombic polymorph of 10,11-dihydrocarbamazepine , Acta Cryst (2006). C62, o240-o242 Â Â Jean-Baptiste Arlin, Louise S. Price, Sarah L. Price and Alastair J. Florence.
A strategy for producing predicted polymorphs: catemeric carbamazepine form V, Chem. Commun., 2011, 47, 7074. X-ray crystallographic characterization of 10,11-dihydro-5H-dibenz[b, f ]azepine-5-carboxamide, Journal of Crystallographic and Spectroscopic Research Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography, Analytical and Bioanalytical Chemistry Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma, Analytical and Bioanalytical Chemistry Determination of carbamazepine and 12 degradation products in various compartments of an outdoor aquatic mesocosm by reliable analytical methods based on liquid chromatography-tandem mass spectrometry, Environmental Science and Pollution Research